Avedro Competitors and Similar CompaniesClear all
Avedro's competitors and similar companies include Antares Pharma and OptiNose.
 Avedro Avedro is a medical device and pharmaceutical company that produces and delivers drugs and devices for corneal remodeling to eye care professionals. |  Antares Pharma Antares Pharma is a specialty pharmaceutical company which focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. | ||
Founding Date | Founding Date 2002 | Founding Date 1979 | Founding Date 2000 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Waltham, US HQ | Locations Ewing, US HQ Hopkins, US Plymouth, US | Locations Morrisville, US HQ Oslo, NO Swindon, GB |
Employees | Employees 122 | Employees 1788% increase | Employees 2048% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 950.5 m | Valuation ($) 118.1 m |
Financial | |||
Revenue (est.) | Revenue (est.) $27.7m (FY, 2018) | Revenue (est.) $184m (FY, 2021) | Revenue (est.) $78.2m (FY, 2024) |
Cost of goods | Cost of goods $10.9m (FY, 2018) | Cost of goods N/A | Cost of goods $7.2m (FY, 2024) |
Gross profit | Gross profit $16.8m (FY, 2018) | Gross profit N/A | Gross profit $71m (FY, 2024) |
Net income | Net income ($25.1m) (FY, 2018) | Net income $46.3m (FY, 2021) | Net income ($21.5m) (FY, 2024) |
Operating ⚠ | |||
Patents (US) | Patents (US) 15 (Mar, 2019) | Patents (US) N/A | Patents (US) 43 (Jun, 2017) |
Trademarks (US) | Trademarks (US) 10 (Mar, 2019) | Trademarks (US) N/A | Trademarks (US) 3 (Jun, 2017) |
Funding | |||
Total funding raised | Total funding raised $ 67.6m | Total funding raised N/A | Total funding raised $ 120.5m |
For sources of this data, please see the company profile
View Company Profiles
Antares Pharma
HQ
Ewing, US
Employees
178↑ 8% increase
Antares Pharma is a specialty pharmaceutical company which focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies.
View company
OptiNose
HQ
Morrisville, US
Employees
204↓ 8% decrease
OptiNose develops nasal drug delivery technologies and combination drug-device therapies.
View company